• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫功能低下宿主的肺结核——第30个B系列化疗对照试验报告——日本国立疗养院肺结核化疗合作研究组]

[Pulmonary tuberculosis in the compromised host--report of the 30th B series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanatoria in Japan].

作者信息

Tubura E

机构信息

Toneyama National Hospital, Osaka, Japan.

出版信息

Kekkaku. 1991 Feb;66(2):95-9.

PMID:2023364
Abstract

The 445 cases of pulmonary tuberculosis in compromised host were investigated. Summary of the analysed results were as follows; (1) The major underlying diseases of compromised hosts with tuberculosis were diabetes mellitus and various types of cancer. (2) The major risk factors for advancement of tuberculosis were malnutrition and iatrogenic suppressions due to long term use of corticosteroids and anticancer agents. (3) The patients with malnutrition in the compromised hosts showed poor prognosis. (4) The chest roentgenogram of tuberculous lesion was difficult to improve in these patients when their clinical stage of tuberculosis had been advanced at admission. (5) The diagnosis and management of pulmonary tuberculosis in compromised host remain as a serious problem in recent years.

摘要

对445例免疫功能低下宿主的肺结核病例进行了调查。分析结果总结如下:(1) 患有肺结核的免疫功能低下宿主的主要基础疾病是糖尿病和各类癌症。(2) 结核病进展的主要危险因素是营养不良以及长期使用皮质类固醇和抗癌药物导致的医源性免疫抑制。(3) 免疫功能低下宿主中营养不良的患者预后较差。(4) 当这些患者入院时结核病临床分期已进展时,其结核病灶的胸部X线片很难改善。(5) 近年来,免疫功能低下宿主肺结核的诊断和管理仍然是一个严重问题。

相似文献

1
[Pulmonary tuberculosis in the compromised host--report of the 30th B series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanatoria in Japan].[免疫功能低下宿主的肺结核——第30个B系列化疗对照试验报告——日本国立疗养院肺结核化疗合作研究组]
Kekkaku. 1991 Feb;66(2):95-9.
2
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
3
[Pulmonary tuberculosis and diabetes mellitus--report of the 29th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].[肺结核与糖尿病——第29次B系列化疗对照试验报告。日本国立疗养院肺结核化疗合作研究组(CSUCTNS)]
Kekkaku. 1989 Nov;64(11):699-705.
4
[Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].异烟肼和利福平治疗肺结核病例细菌学复发情况的调查——日本国立疗养院结核病化疗第27个B系列对照试验报告。日本国立疗养院结核病化疗合作研究组(CSUCTNS)
Kekkaku. 1987 May;62(5):265-80.
5
[Actual condition and chemotherapy of extrapulmonary tuberculosis in national sanatoria. (An observation in intestinal tuberculosis and tuberculous peritonitis)--report of the B series of 26th controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
Kekkaku. 1986 Apr;61(4):243-52.
6
[Evaluation of short-term chemotherapy of pulmonary tuberculosis (2). (a trial of 6-month chemotherapy following negative conversion of the sputum)--a report on the 19th and 20th controlled trials series A of chemotherapy by the Cooperative Study Unit, Japan National Sanatoria)].[肺结核短期化疗的评估(2)。(痰菌转阴后6个月化疗试验)——日本国立疗养院合作研究组化疗第19和20次对照试验A系列报告]
Kekkaku. 1983 Jun;58(6):347-53.
7
[Clinical trial of initial intensive short-course chemotherapy supplemented by pyrazinamide for pulmonary tuberculosis--report of the 26th A series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].吡嗪酰胺辅助初始强化短程化疗治疗肺结核的临床试验——日本国立疗养院结核病化疗协作研究组第26次化疗对照试验系列报告(CSUCTNS)
Kekkaku. 1986 Jul;61(7):363-9.
8
[A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
Kekkaku. 1984 Feb;59(2):81-9.
9
[The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].[耐药性肺结核的现状、治疗及预后。日本国立疗养院结核病化疗合作研究组]
Kekkaku. 1995 Oct;70(10):585-9.
10
[A survey of the initial course of tuberculosis chemotherapy under compulsory hospitalization on the basis of the revised Tuberculosis Prevention Law--report of the 32nd C series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanatoria in Japan].基于修订后的《结核病预防法》进行的结核病化疗强制住院初期疗程调查——第32次C系列化疗对照试验报告——日本国立疗养院结核病化疗合作研究组
Kekkaku. 1993 Jul;68(7):487-93.

引用本文的文献

1
Retrospective evaluation of active tuberculosis cases in terms of chemoprophylaxis indication: A cross-sectional study.根据化学预防指征对活动性肺结核病例进行回顾性评估:一项横断面研究。
Medicine (Baltimore). 2025 Jul 4;104(27):e43202. doi: 10.1097/MD.0000000000043202.